Pages that link to "Q59651629"
Jump to navigation
Jump to search
The following pages link to Region- and Type-Specific Induction of Matrix Metalloproteinases in Post–Myocardial Infarction Remodeling (Q59651629):
Displaying 50 items.
- Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction (Q24673841) (← links)
- Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors (Q26830555) (← links)
- Translating Koch's postulates to identify matrix metalloproteinase roles in postmyocardial infarction remodeling: cardiac metalloproteinase actions (CarMA) postulates (Q26865099) (← links)
- Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology (Q28300693) (← links)
- Early citalopram treatment increases mortality due to left ventricular rupture in mice after myocardial infarction (Q30314082) (← links)
- Multimodality imaging of myocardial injury and remodeling (Q30432655) (← links)
- Myocardial dysfunction in the periinfarct and remote regions following anterior infarction in rats quantified by 2D radial strain echocardiography: an observational cohort study (Q30494346) (← links)
- Membrane-associated matrix proteolysis and heart failure. (Q33632033) (← links)
- Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition (Q33650887) (← links)
- Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice (Q33696289) (← links)
- Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction (Q33976308) (← links)
- Dor procedure for dyskinetic anteroapical myocardial infarction fails to improve contractility in the border zone (Q34011082) (← links)
- Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model. (Q34065859) (← links)
- Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction (Q34144778) (← links)
- Long-term localized high-frequency electric stimulation within the myocardial infarct: effects on matrix metalloproteinases and regional remodeling (Q34158455) (← links)
- Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury (Q34378881) (← links)
- Heterogeneity in MT1-MMP activity with ischemia-reperfusion and previous myocardial infarction: relation to regional myocardial function (Q34426181) (← links)
- Discordant Activation of Gene Promoters for Matrix Metalloproteinases and Tissue Inhibitors of the Metalloproteinases Following Myocardial Infarction (Q34441099) (← links)
- Infarct restraint to limit adverse ventricular remodeling (Q34491735) (← links)
- Dynamic cardiac dyssynchrony is strongly associated with 2-year dialysis adequacy in continuous ambulatory peritoneal dialysis patients (Q34632496) (← links)
- Elimination of Ischemic Mitral Regurgitation Does Not Alter Long-Term Left Ventricular Remodeling in the Ovine Model (Q34814017) (← links)
- Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt (Q34967047) (← links)
- Myocardial remodeling: cellular and extracellular events and targets (Q35168352) (← links)
- Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction (Q35194787) (← links)
- Protease-degradable electrospun fibrous hydrogels (Q35213164) (← links)
- Toll-like receptor 4 mediates the inflammatory responses and matrix protein remodeling in remote non-ischemic myocardium in a mouse model of myocardial ischemia and reperfusion (Q35230933) (← links)
- Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodeling (Q35396616) (← links)
- Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction (Q35458472) (← links)
- Targeted regional injection of biocomposite microspheres alters post-myocardial infarction remodeling and matrix proteolytic pathways (Q35556858) (← links)
- Modification of infarct material properties limits adverse ventricular remodeling (Q35662201) (← links)
- The potential role of ventricular compressive therapy (Q35724546) (← links)
- Reading tarot cards (Q35724728) (← links)
- MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction (Q35951850) (← links)
- Inhibition of ischemic cardiomyocyte apoptosis through targeted ablation of Bnip3 restrains postinfarction remodeling in mice (Q36014531) (← links)
- Post-infarct biomaterials, left ventricular remodeling, and heart failure: is good good enough? (Q36188261) (← links)
- Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction (Q36203101) (← links)
- Disruptions and detours in the myocardial matrix highway and heart failure (Q36203117) (← links)
- Screening for ventricular remodeling (Q36473364) (← links)
- Recent insights into cardiac hypertrophy and left ventricular remodeling. (Q36473369) (← links)
- Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats (Q36621513) (← links)
- Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: moving beyond collagen expression (Q36699619) (← links)
- Left ventricular myocardial contractility is depressed in the borderzone after posterolateral myocardial infarction (Q36806806) (← links)
- Moderate Ischemic Mitral Regurgitation After Posterolateral Myocardial Infarction in Sheep Alters Left Ventricular Shear but Not Normal Strain in the Infarct and Infarct Borderzone (Q36828360) (← links)
- Matrix metalloproteinases and myocardial infarction (Q36876035) (← links)
- Targeted myocardial microinjections of a biocomposite material reduces infarct expansion in pigs (Q37148466) (← links)
- Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass (Q37151445) (← links)
- Matrix metalloproteinases and cardiovascular diseases. (Q37195730) (← links)
- Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) (Q37232591) (← links)
- Heterogeneity of left ventricular wall thickening mechanisms (Q37337641) (← links)
- Cardiac-restricted overexpression of membrane type-1 matrix metalloproteinase in mice: effects on myocardial remodeling with aging (Q37344462) (← links)